Center focused on finding cure for glioblastoma reveals AstraZeneca drug may be a success
A small molecule kinase inhibitor has been trialed in humans for the first time as part of a glioblastoma treatment study.
Archives for October 20, 2023
Amylyx Pharmaceuticals hopes to launch largest PSP trial to date by the end of 2023
The treatment of rare brain disease, progressive supranuclear palsy (PSP), that has no disease modifying therapies, has been given a glimmer of hope by Amylyx Pharmaceuticals.
Interview: CRO Emmes on the unique challenges of clinical trials using psychedlics and the FDA guidance
Feedback has been submitted to the US Food and Drug Administration (FDA) with guidelines intended for sponsors of clinical trials related to psychedelic compounds.
Empatica and the importance of wearable devices in getting the full patient profile
Matteo Lai was part of a panel at DPharm in Boston this year, it was called working together to accelerate the adoption of digital biomarkers in clinical trials.
New deep brain stimulation could improve memory loss in Alzheimer’s patients
Researchers at the UK Dementia Research Institute have developed a new form of deep brain stimulation that does not require surgery and could provide an alternative treatment option for debilitating brain diseases such as Alzheimer’s.
DPHARM 2023
Greenphire's Dave Hine's reflections on DPharm 2023 - and how 'rising tide lifts all boats'
Dave Hine is the senior director of sales engineering at Greenphire. He has been reflecting on his time at DPharm and the collaborative approach to life sciences.